• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利肥胖儿童队列中肝内脂肪含量的遗传和代谢预测因子。

Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity.

机构信息

Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, 00161, Rome, Italy.

Department of Pediatrics, Sapienza University of Rome, 00161, Rome, Italy.

出版信息

Pediatr Res. 2019 Apr;85(5):671-677. doi: 10.1038/s41390-019-0303-1. Epub 2019 Jan 23.

DOI:10.1038/s41390-019-0303-1
PMID:30710115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6760560/
Abstract

OBJECTIVES

To comprehensively explore metabolic and genetic contributors to liver fat accumulation in overweight/obese children.

METHODS

Two hundred thirty Italian children with obesity were investigated for metabolic parameters and genotyped for PNPLA3, TM6SF2, GCKR, and MBOAT7 gene variants. Percentage hepatic fat content (HFF%) was measured by nuclear magnetic resonance.

RESULTS

HFF% was positively related with BMI, HOMA, metabolic syndrome, ALT, AST, γGT, and albumin. Carriers of [G] allele in PNPLA3, [T] allele in GCKR and [T] allele in TM6SF2 genes had significantly higher hepatic fat content than wild-type carriers. HFF% was explained for 8.7% by metabolic and for 16.1% by genetic factors and, a model including age, gender, BMI, HOMA, PNPLA3, GCKR, and TM6SF2 variants was the best predictor of HFF%, explaining 24.8% of its variation (P < 0.001). A weighted-genetic risk score combining PNPLA3, GCKR, and TM6SF2 risk alleles was associated with almost eightfold higher risk of NAFLD.

CONCLUSIONS

Our data highlighted the predominant role of genetic factors in determining the amount of liver fat content in children with obesity.

摘要

目的

全面探讨超重/肥胖儿童肝脂肪堆积的代谢和遗传因素。

方法

对 230 名意大利肥胖儿童进行代谢参数调查,并对 PNPLA3、TM6SF2、GCKR 和 MBOAT7 基因变异进行基因分型。采用磁共振技术测量肝脂肪含量百分比(HFF%)。

结果

HFF%与 BMI、HOMA、代谢综合征、ALT、AST、γGT 和白蛋白呈正相关。PNPLA3 基因的[G]等位基因、GCKR 基因的[T]等位基因和 TM6SF2 基因的[T]等位基因携带者的肝脂肪含量明显高于野生型携带者。代谢因素可解释 HFF%的 8.7%,遗传因素可解释 16.1%,包括年龄、性别、BMI、HOMA、PNPLA3、GCKR 和 TM6SF2 变异在内的模型是 HFF%的最佳预测因子,可解释其变异的 24.8%(P<0.001)。结合 PNPLA3、GCKR 和 TM6SF2 风险等位基因的加权遗传风险评分与非酒精性脂肪性肝病的风险增加近 8 倍相关。

结论

我们的数据强调了遗传因素在决定肥胖儿童肝脂肪含量方面的主要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feae/6760560/9e6dbdb707c4/41390_2019_303_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feae/6760560/49d73a0e00b7/41390_2019_303_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feae/6760560/9e6dbdb707c4/41390_2019_303_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feae/6760560/49d73a0e00b7/41390_2019_303_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feae/6760560/9e6dbdb707c4/41390_2019_303_Fig2_HTML.jpg

相似文献

1
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity.意大利肥胖儿童队列中肝内脂肪含量的遗传和代谢预测因子。
Pediatr Res. 2019 Apr;85(5):671-677. doi: 10.1038/s41390-019-0303-1. Epub 2019 Jan 23.
2
Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.台湾地区儿童肝脂肪变性和血清细胞角蛋白 18 片段水平的遗传决定因素。
Liver Int. 2018 Jul;38(7):1300-1307. doi: 10.1111/liv.13689. Epub 2018 Jan 24.
3
The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth.MBOAT7 基因中的 rs626283 变异与白种肥胖青少年的胰岛素抵抗和脂肪肝有关。
Am J Gastroenterol. 2018 Mar;113(3):376-383. doi: 10.1038/ajg.2018.1. Epub 2018 Feb 27.
4
Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.PNPLA3基因rs738409、TM6SF2基因rs58542926和MBOAT7基因rs641738变异对非酒精性脂肪性肝病严重程度的联合影响:一项基于多中心活检的研究。
J Lipid Res. 2017 Jan;58(1):247-255. doi: 10.1194/jlr.P067454. Epub 2016 Nov 11.
5
Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.遗传风险评分对肥胖儿童和青少年肝脂肪变性的临床预测的贡献。
Dig Liver Dis. 2019 Nov;51(11):1586-1592. doi: 10.1016/j.dld.2019.05.029. Epub 2019 Jun 27.
6
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children.非酒精性脂肪性肝病(NAFLD),而非其易感性基因变异,影响超重/肥胖儿童肾功能的下降。
Int J Mol Sci. 2019 Sep 9;20(18):4444. doi: 10.3390/ijms20184444.
7
Relevance of , , , and Variants to MASLD Severity in an Egyptian Population.[具体基因名称]、[具体基因名称]、[具体基因名称]和[具体基因名称]变体与埃及人群中代谢相关脂肪性肝病严重程度的相关性
Genes (Basel). 2024 Apr 4;15(4):455. doi: 10.3390/genes15040455.
8
The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.膜结合 O-酰基转移酶 7 rs641738 变异与儿童非酒精性脂肪性肝病。
J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):69-74. doi: 10.1097/MPG.0000000000001979.
9
NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.载脂蛋白 L1、TM6SF2、GCKR 和 LYPLAL1 中的非酒精性脂肪性肝病风险等位基因显示出不同的代谢效应。
Hum Mol Genet. 2018 Jun 15;27(12):2214-2223. doi: 10.1093/hmg/ddy124.
10
PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.PNPLA3基因的p.I148M变异与减肥手术后肝脏脂肪含量的更大幅度降低有关。
Surg Obes Relat Dis. 2016 Dec;12(10):1838-1846. doi: 10.1016/j.soard.2016.06.004. Epub 2016 Jul 1.

引用本文的文献

1
MASLD in children: integrating epidemiological trends with mechanistic and translational advances.儿童代谢相关脂肪性肝病:将流行病学趋势与机制及转化研究进展相结合
J Clin Invest. 2025 Jul 1;135(13). doi: 10.1172/JCI186422.
2
The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH.循环 D-环和 mt-ccf 水平的无创评估为 NASH 的棘手诊断开辟了新颖方法的有趣窥探窗口。
Int J Mol Sci. 2023 Jan 24;24(3):2331. doi: 10.3390/ijms24032331.
3
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review.

本文引用的文献

1
Genetics of alcoholic liver disease and non-alcoholic steatohepatitis.酒精性肝病和非酒精性脂肪性肝炎的遗传学。
Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s54-s59. doi: 10.7861/clinmedicine.18-2-s54.
2
The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.膜结合 O-酰基转移酶 7 rs641738 变异与儿童非酒精性脂肪性肝病。
J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):69-74. doi: 10.1097/MPG.0000000000001979.
3
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.
非酒精性脂肪性肝病(NAFLD)中的基因多态性与多样性:一篇综述短文
Biomedicines. 2022 Dec 30;11(1):106. doi: 10.3390/biomedicines11010106.
4
Factors early in life associated with hepatic steatosis.生命早期与肝脂肪变性相关的因素。
World J Hepatol. 2022 Jun 27;14(6):1235-1247. doi: 10.4254/wjh.v14.i6.1235.
5
Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease.血清生物标志物和联合诊断标志物在非酒精性脂肪性肝病中的研究进展。
Dis Markers. 2022 Jun 29;2022:1254014. doi: 10.1155/2022/1254014. eCollection 2022.
6
Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease.代谢综合征而非脂肪肝相关基因变异与非酒精性脂肪性肝病患者的肾小球肾功能下降相关。
Biomedicines. 2022 Mar 19;10(3):720. doi: 10.3390/biomedicines10030720.
7
Genetics Is of the Essence to Face NAFLD.遗传学对于应对非酒精性脂肪性肝病至关重要。
Biomedicines. 2021 Sep 30;9(10):1359. doi: 10.3390/biomedicines9101359.
8
The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity.PNPLA3基因rs738409变异而非MBOAT7基因rs641738变异是美国肥胖西班牙裔儿童非酒精性脂肪性肝病的危险因素。
Pediatr Gastroenterol Hepatol Nutr. 2021 Sep;24(5):455-469. doi: 10.5223/pghn.2021.24.5.455. Epub 2021 Sep 8.
9
Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study.基于脂肪肝指数、磁共振成像和脂质组学的三种不同遗传风险评分用于非酒精性脂肪性肝病的营养遗传个性化管理:肥胖中的脂肪肝研究
Diagnostics (Basel). 2021 Jun 13;11(6):1083. doi: 10.3390/diagnostics11061083.
10
New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease.儿童代谢相关脂肪性肝病基因预测的新视角
Front Pediatr. 2020 Dec 9;8:603654. doi: 10.3389/fped.2020.603654. eCollection 2020.
基于候选基因重测序策略评估非酒精性脂肪性肝病(NAFLD)的多基因决定因素。
Sci Rep. 2018 Feb 27;8(1):3702. doi: 10.1038/s41598-018-21939-0.
4
The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth.MBOAT7 基因中的 rs626283 变异与白种肥胖青少年的胰岛素抵抗和脂肪肝有关。
Am J Gastroenterol. 2018 Mar;113(3):376-383. doi: 10.1038/ajg.2018.1. Epub 2018 Feb 27.
5
Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.台湾地区儿童肝脂肪变性和血清细胞角蛋白 18 片段水平的遗传决定因素。
Liver Int. 2018 Jul;38(7):1300-1307. doi: 10.1111/liv.13689. Epub 2018 Jan 24.
6
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.非酒精性脂肪肝中肝脂肪与肝损伤和胰岛素抵抗的因果关系。
J Intern Med. 2018 Apr;283(4):356-370. doi: 10.1111/joim.12719. Epub 2017 Dec 27.
7
Non-alcoholic fatty liver disease: An expanded review.非酒精性脂肪性肝病:扩展综述
World J Hepatol. 2017 Jun 8;9(16):715-732. doi: 10.4254/wjh.v9.i16.715.
8
Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.低出生体重增加了儿科非酒精性脂肪性肝病严重脂肪变性的可能性。
Am J Gastroenterol. 2017 Aug;112(8):1277-1286. doi: 10.1038/ajg.2017.140. Epub 2017 May 30.
9
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.非酒精性脂肪性肝病与亚临床动脉粥样硬化:代谢性与遗传性肝内脂肪蓄积所致的对比。
Atherosclerosis. 2017 Feb;257:232-239. doi: 10.1016/j.atherosclerosis.2016.12.018. Epub 2016 Dec 21.
10
The ExAC browser: displaying reference data information from over 60 000 exomes.ExAC浏览器:展示来自6万多个外显子组的参考数据信息。
Nucleic Acids Res. 2017 Jan 4;45(D1):D840-D845. doi: 10.1093/nar/gkw971. Epub 2016 Nov 28.